BRIEF-Medigus Polyrizon To Initiate Processes Towards FDA Submission
BRIEF-Medigus Polyrizon To Initiate Processes Towards FDA Submission
簡報-Medigus Polyrizon將啟動向FDA提交的程序
Oct 22 (Reuters) - Medigus Ltd 2QMy.F :
路透10月22日電-Medigus Ltd 2QMy.F：
* MEDIGUS: POLYRIZON TO INITIATE PROCESSES TOWARDS FDA SUBMISSION
*Medigus：POLYRIZON將啟動向FDA提交的程序
* MEDIGUS LTD - POLYRIZON ENGAGED WITH A CRO TO OVERSEE POLYRIZON'S EFFORTS FOR FDA SUBMISSION OF ITS CORONAVIRUS AND ALLERGEN PREVENTATIVE PRODUCTS
*Medigus Ltd-POLYRIZON與CRO合作，監督POLYRIZON為FDA提交其冠狀病毒和過敏原預防產品所做的努力
Source text for Eikon: ID:nGNXN311H Further company coverage: 2QMy.F
Eikon的源文本：ID：nGNXN311H進一步的公司報道：2QMy.F
((Reuters.Briefs@thomsonreuters.com;))
(Reurs.Briefs@thomsonreurs.com；)